Pulmonary vascular disease & thromboembolismCohort study

Invasive and non-invasive mapping of the cardiac electromechanical substrate in pulmonary arterial hypertension

Heart RhythmPublished

  • Prospective mapping study
  • non-invasive electrocardiographic imaging
  • invasive right atrial (RA) electroanatomical mapping during ablation
  • matched controls

Authors' conclusion

RA dilatation in PAH and CTEPH is associated with slowed conduction, prolonged repolarization, and increased AV nodal refractoriness, providing a mechanistic substrate for atrial arrhythmias and conduction disease. These findings highlight structural-electrophysiological correlations that may guide arrhythmia risk assessment and targeted interventions in PH.

Study context

Population
Adult patients with pulmonary arterial hypertension (PAH) or chronic thromboembolic pulmonary hypertension (PH) (chronic thromboembolic PH (CTEPH))non-invasive electrocardiographic imaging 30 · invasive RA electroanatomical mapping during ablation 10
Exposure
PAH patients vs matched controls

Main finding

As reported in the abstract

Atrial activation time (non-invasive mapping)

PAH patients

72 ± 17

ms

matched controls

46 ± 12

ms

P = 0.001

Observational data: associations, not effects.

Further findings

OutcomePAH patientsmatched controlsP value
Ventricular activation time (non-invasive mapping) · prolonged in PAH patients41 ± 13 ms31 ± 6 msP = 0.009
Ventricular repolarization time (non-invasive mapping) · prolonged in PAH patients127 ± 51 ms87 ± 25 msP = 0.007
Ventricular activation-recovery interval (non-invasive mapping) · prolonged in PAH patients292 ± 30 ms246 ± 25 msP = 0.001

RA dilatation vs atrial conduction and repolarization (non-invasive mapping)

slower atrial conduction R
R = 0.51, P = .01
prolonged repolarization R
R = 0.40, P = .02

RA volume vs atrial conduction velocity and atrioventricular (AV) nodal effective refractory period (invasive mapping)

atrial conduction velocity R
R = −0.64, P = .05
atrioventricular (AV) nodal effective refractory period R
R = 0.82, P = .03

Original publication

Invasive and non-invasive mapping of the cardiac electromechanical substrate in pulmonary arterial hypertension. Heart Rhythm. Published 27 August 2026. doi:10.1016/j.hrthm.2026.08.036

Summarised from the published abstract; every number is checked against it